Patent Assignment
Reel/Frame 015509/0948
Assignment of Assignor's Interest
Recorded: 2004-06-30
Pages: 18
Assignor
IGEN INTERNATIONAL, INC.
Executed: 2004-02-10
Assignee
PROTEINIX, INC.
930 CLOPPER ROAD, GAITHERSBURG, MARYLAND, 20878
Covered Properties
(40)
Method of Catalyzing Chemical Reactions
Patent:
4,888,281 →
Application:
06/674,253 →
Production of Antibody Catalysts
Patent:
4,792,446 →
Application:
06/877,273 →
Production of Antibody Catalysts
Patent:
4,963,355 →
Application:
07/064,239 →
Method for Producing Antibodies Which Catalyze Chemical Reactions
Patent:
5,037,750 →
Application:
07/411,547 →
Inhibitors of Catalytic Antibodies
Patent:
5,194,585 →
Application:
07/486,594 →
Catalytic Antibodies
Patent:
5,156,965 →
Application:
07/730,125 →
Therapeutic Methods Using Catalytic Antibodies
Application:
07/761,868 →
Monoclonal Antibody and Antibody Components Elicited to a Polypeptide Antigen Ground State
Patent:
5,318,897 →
Application:
07/789,344 →
Interaction System Comprising a Surfactant-Stabilized Aqueous Phase Containing an Antibody Fragment
Patent:
5,314,642 →
Application:
07/938,489 →
Production of Antibody Catalysts
Patent:
5,401,641 →
Application:
08/073,285 →
Catalytic Antibodies as Chemical Sensors
Patent:
6,846,654 →
Application:
08/090,245 →
Autoantibodies Which Enhance the Rate of a Chemical Reaction
Patent:
5,602,015 →
Application:
08/259,151 →
Isolation and Production of Catalytic Antibodies Using Phage Technology
Patent:
5,855,885 →
Application:
08/273,146 →
Autoantibodies Which Enhance the Rate of a Chemical Reaction
Patent:
5,599,538 →
Application:
08/274,306 →
Prodrugs Activated by Targeted Catalytic Proteins
Application:
08/325,540 →
Prodrugs Activated by Targeted Catalytic Proteins
Patent:
6,258,360 →
Application:
08/325,554 →
Transition State Analogs
Patent:
5,952,462 →
Application:
08/333,237 →
Catalytic Antibodies Which Hydrolyze Primary Amides and Methods for Eliciting Such Antibodies
Patent:
5,900,237 →
Application:
08/362,470 →
Reaction-Based Selection for Expression of and Concentration of Catalytic Moieties
Patent:
5,631,137 →
Application:
08/377,495 →
Prodrugs Activated by Targeted Catalytic Proteins
Patent:
6,702,705 →
Application:
08/392,407 →
Catalytic Antibody Components
Patent:
5,658,753 →
Application:
08/402,158 →
Lipid-A Analogs: New Monosaccharide and Disaccharide Intermediates for Eliciting Therapeutic Antibodies and for Antitumor and Antiviral Activities
Patent:
5,597,573 →
Application:
08/405,438 →
Catalytic Antibodies
Patent:
7,205,136 →
Application:
08/447,924 →
Peptide Analogs and Their Use as Haptens to Elicit Catalytic Antibodies
Application:
08/471,140 →
Inhibitors of Catalytic Antibodies
Patent:
6,048,717 →
Application:
08/478,285 →
Method of Catalyzing Chemical Reactions
Patent:
5,658,752 →
Application:
08/478,355 →
Method of Catalyzing Stereochemical Reactions
Patent:
6,057,121 →
Application:
08/478,954 →
Methods for Enhancing the Rate of Modification of Metastable Bonds
Patent:
6,521,432 →
Application:
08/479,849 →
Catalytic Antibodies Which Hydrolyze Primary Amides and Methods for Eliciting and Use of Such Antibodies
Patent:
6,479,265 →
Application:
08/524,920 →
Reaction-Based Selection for Expression of and Concentration of Catalytic Moieties
Patent:
6,121,007 →
Application:
08/747,654 →
Reaction-Based Selection for Expression of and Concentration of Catalytic Moieties
Patent:
5,891,648 →
Application:
08/748,415 →
Reaction-Based Selection for Expression of and Concentration of Catalytic Moieties
Patent:
6,177,270 →
Application:
09/235,353 →
Catalytic Antibodies Which Hydrolyze Primary Amides and Methods for Eliciting Such Antibodies
Application:
09/241,876 →
Transition State Analogs
Patent:
6,946,272 →
Application:
09/303,716 →
Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
Application:
09/817,502 →
Publication:
US 2002/0045231
Methods and compositions for modifying biologically active target molecules
Application:
10/039,471 →
Publication:
US 2002/0182207
Prodrugs activated by targeted catalytic proteins
Application:
10/205,115 →
Publication:
US 2003/0096765
Method for Selectively Applying Solder Mask
Prodrugs activated by targeted catalytic proteins
Application:
10/699,966 →
Publication:
US 2005/0123533
Methods and compositions for modifying biologically active target molecules
Application:
60/242,125 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Nov 27, 1984
From: SCHOCHETMAN, GERALD; MASSEY, RICHARD J.
To: IGEN, INC.
Reel/Frame 004340/0116 →
Assignment of Assignors Interest.
Sep 26, 1988
From: MOLECULAR BIOPHYSICS TECHNOLOGY, INC.,
To: IGEN, INC., A CORP. OF CA
Reel/Frame 004962/0063 →
Assignment of Assignors Interest.
Sep 26, 1988
From: KIM, PETER S.; KALLENBACH, NEVILLE R.
To: MOLECULAR BIOPHYSICS TECHNOLOGY, INC.
Reel/Frame 004962/0060 →
Assignment of Assignors Interest.
Sep 26, 1988
From: KIM, PETER S.
To: MOLECULAR BIOPHYSICS TECHNOLOGY, INC.
Reel/Frame 004962/0068 →
Assignment of Assignors Interest.
Sep 26, 1988
From: MOLECULAR BIOPHYSICS TECHNOLOGY, INC.
To: IGEN INC.
Reel/Frame 005000/0784 →
Assignment of Assignors Interest.
Sep 26, 1988
From: KIM, PETER S.
To: MOLECULAR BIOPHYSICS TECHNOLOGY, INC.
Reel/Frame 005000/0790 →
Assignment of Assignors Interest.
Sep 26, 1988
From: KIM, PETER S.; KALLENBACH, NEVILLE R.
To: MOLECULAR BIOPHYSICS TECHNOLOGY, INC.
Reel/Frame 005000/0793 →
Assignment of Assignors Interest.
Sep 26, 1988
From: MOLECULAR BIOPHYSICS TECHNOLOGY, INC., A CORP. OF DE
To: IGEN, INC., A CORP. OF CA
Reel/Frame 005005/0589 →
Assignment of Assignors Interest.
May 14, 1990
From: PAUL, SUDHIR; POWELL, MICHAEL J.; MASSEY, RICHARD J.
To: IGEN, INC., A CORP. OF CA
Reel/Frame 005319/0001 →
Assignment of Assignors Interest.
Feb 10, 1992
From: PAUL, SUDHIR
To: IGEN, INC.
Reel/Frame 006020/0916 →
Assignment of Assignor's Interest
Aug 23, 1995
From: HANSEN, DAVID E.
To: IGEN, INC.
Reel/Frame 007693/0933 →
Assignment of Assignor's Interest
Mar 9, 1998
From: NAPPER, ANDREW D.; TITMAS, RICHARD C.; MARTIN, MARK T.
To: IGEN INTERNATIONAL, INC.
Reel/Frame 009030/0602 →
Merger
Aug 14, 1998
From: IGEN, INC.
To: IGEN INTERNATIONAL, INC.
Reel/Frame 009396/0070 →
Assignment of Assignor's Interest
Feb 3, 2010
From: PROTEINIX CORPORATION
To: WELLSTAT BIOCATALYSIS, LLC
Reel/Frame 023892/0180 →
Security Agreement
Aug 15, 2013
From: WELLSTAT BIOCATALYSIS, LLC
To: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 031030/0520 →
Security Agreement
Sep 17, 2013
From: WELLSTAT BIOCATALYSIS, LLC
To: PDL BIOPHARMA, INC.
Reel/Frame 031227/0172 →
Release of Security Interest
Jan 19, 2021
From: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
To: WELLSTAT BIOCATALYSIS, LLC
Reel/Frame 054950/0281 →